Vasotocin(CAS: 9034-50-8)

Vasotocin (CAS: 9034-50-8) is subject to various regulatory guidelines. Globally, it falls under the Chemicals of Very High Concern (vHCS) under REACH regulations in the EU. In the USA, the FDA regulates its pharmaceutical use, requiring registration with the DEA for controlled substances. EPA regulations govern its environmental handling and disposal. Always consult the latest regulatory databases for specific requirements.

Yes, there are alternatives to Vasotocin (CAS: 9034-50-8) in synthesis. Analogues such as oxytocin and synthetic vasopressin are commonly used. Isomers like desmopressin serve as effective substitutes. Common alternative reagents include arginine vasopressin and synthetic analogues. These alternatives offer similar bioactivity but with varying chemical structures.

The market for Vasotocin (CAS: 9034-50-8) is steadily growing, driven by its therapeutic applications in treating bedwetting and certain kidney disorders. Research trends include exploring its use in neurodegenerative diseases and pain management. Market trends show increasing interest in natural and synthetic vasopressin analogues. Price trends reflect demand in clinical trials and commercial applications.

Waste containing Vasotocin (CAS: 9034-50-8) should be handled following strict safety protocols. Collect waste liquids in appropriate containers and seal them. Incineration is a recommended method for disposal, ensuring proper ventilation and safety measures are in place. Professional waste disposal services are also advisable. Always follow local environmental protection guidelines and regulations for safe disposal.